Randall Owen

Summary

Affiliation: Bristol-Myers Squibb
Country: USA

Publications

  1. ncbi Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder
    Randall Owen
    Bristol Myers Squibb, 5 Research Parkway, Wallingford, Connecticut 06492, USA
    Pediatrics 124:1533-40. 2009
  2. ncbi Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study
    Ronald N Marcus
    Department of Research and Development, Bristol Myers Squibb, 5 Research Parkway, Wallingford, CT 06492, USA
    J Clin Psychiatry 72:1270-6. 2011
  3. ncbi Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study
    Ronald N Marcus
    Bristol Myers Squibb, Wallingford, Connecticut, USA
    J Child Adolesc Psychopharmacol 21:229-36. 2011
  4. ncbi A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder
    Ronald N Marcus
    Bristol Myers Squibb, 5 Research Parkway, Wallingford, CT 06492, USA
    J Am Acad Child Adolesc Psychiatry 48:1110-9. 2009

Detail Information

Publications4

  1. ncbi Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder
    Randall Owen
    Bristol Myers Squibb, 5 Research Parkway, Wallingford, Connecticut 06492, USA
    Pediatrics 124:1533-40. 2009
    ....
  2. ncbi Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study
    Ronald N Marcus
    Department of Research and Development, Bristol Myers Squibb, 5 Research Parkway, Wallingford, CT 06492, USA
    J Clin Psychiatry 72:1270-6. 2011
    ..Evaluate the long-term safety and tolerability of aripiprazole in the treatment of irritability in pediatric subjects (6-17 years) with autistic disorder...
  3. ncbi Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study
    Ronald N Marcus
    Bristol Myers Squibb, Wallingford, Connecticut, USA
    J Child Adolesc Psychopharmacol 21:229-36. 2011
    ..To report the long-term efficacy of aripiprazole in the treatment of irritability in children and adolescents (ages 6-17 years) with autistic disorder...
  4. ncbi A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder
    Ronald N Marcus
    Bristol Myers Squibb, 5 Research Parkway, Wallingford, CT 06492, USA
    J Am Acad Child Adolesc Psychiatry 48:1110-9. 2009
    ..To evaluate the short-term efficacy and safety of aripiprazole in the treatment of irritability in children and adolescents with autistic disorder...